Atlas Trials

n-Lorem Foundation

17 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch n-Lorem Foundation

RecordFirmDate
Personalized Antisense Oligonucleotide Therapy for a Participant With TARDBP ALS (NCT07703462)n-Lorem Foundation2026-12-01
Personalized Antisense Oligonucleotide for A Single Participant With PACS1 Gene Mutation Associated With Schuurs-Hoeijmakers Syndrome (SHMS) (NCT07474298)n-Lorem Foundation2026-04-01
Personalized Antisense Oligonucleotide Therapy for A Single Patient With CHCHD10 ALS (nL18576) (NCT07423494)n-Lorem Foundation2026-03-01
Personalized Antisense Oligonucleotide Therapy for Participants With TARDBP ALS (NCT07743268)n-Lorem Foundation2026-02-19
Personalized Antisense Oligonucleotide for A Single Participant (nL62541) With ATN1 Gene Mutation (NCT07221760)n-Lorem Foundation2025-11-06
Personalized Antisense Oligonucleotide for A Single Participant With GARS1 Gene Mutation Associated With Charcot-Marie-Tooth Disease Type 2D (CMT2D) (NCT07226297)n-Lorem Foundation2025-10-27
Personalized Antisense Oligonucleotide Therapy for a Single Participant With PRPH2 Mutation Associated With Retinal Dystrophy (NCT07177196)n-Lorem Foundation2025-08-28
Personalized Antisense Oligonucleotide Therapy for A Single Participant With ASXL3 Gene Mutation (NCT07197268)n-Lorem Foundation2025-05-19
Personalized Antisense Oligonucleotide Therapy for A Single Participant With LMNB1 Mutation Associated Autosomal Dominant Leukodystrophy (ADLD) (NCT06816498)n-Lorem Foundation2025-03-17
Personalized Antisense Oligonucleotide for a Single Participant With MAPK8IP3 Neurodevelopmental Disorder With or Without Variable Brain Abnormalities (NEDBA) (NCT07197294)n-Lorem Foundation2025-02-24
Personalized Antisense Oligonucleotide for A Single Participant With UBTF Gene Mutation (NCT07588581)n-Lorem Foundation2025-02-05
Personalized Antisense Oligonucleotide Therapy for A Single Participant With TARDBP ALS (NCT07095712)n-Lorem Foundation2024-11-25
Personalized Antisense Oligonucleotide for A Single Participant With ATN1 Gene Mutation (NCT07084311)n-Lorem Foundation2024-10-24
Personalized Antisense Oligonucleotide for Participants With CHCHD10 ALS (NCT07095686)n-Lorem Foundation2024-10-02
Personalized Antisense Oligonucleotide Therapy for A Single Participant With CHCHD10 ALS (NCT06392126)n-Lorem Foundation2024-04-16
Personalized Antisense Oligonucleotide Therapy for A Single Participant With ATN1 Gene Mutation (NCT06706388)n-Lorem Foundation2024-02-21

Track n-Lorem Foundation automatically

Every clearance here is in the API, with alerts when new ones post.